Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Common Equity (2016 - 2025)

Historic Common Equity for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to $37.0 million.

  • Rockwell Medical's Common Equity rose 2706.37% to $37.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.0 million, marking a year-over-year increase of 2706.37%. This contributed to the annual value of $32.6 million for FY2024, which is 5305.06% up from last year.
  • Rockwell Medical's Common Equity amounted to $37.0 million in Q3 2025, which was up 2706.37% from $30.4 million recorded in Q2 2025.
  • Over the past 5 years, Rockwell Medical's Common Equity peaked at $37.0 million during Q3 2025, and registered a low of -$4.8 million during Q1 2022.
  • In the last 5 years, Rockwell Medical's Common Equity had a median value of $20.6 million in 2024 and averaged $19.6 million.
  • Examining YoY changes over the last 5 years, Rockwell Medical's Common Equity showed a top increase of 45644.97% in 2022 and a maximum decrease of 11834.73% in 2022.
  • Rockwell Medical's Common Equity (Quarter) stood at $2.5 million in 2021, then skyrocketed by 456.45% to $14.1 million in 2022, then skyrocketed by 50.94% to $21.3 million in 2023, then surged by 53.05% to $32.6 million in 2024, then grew by 13.61% to $37.0 million in 2025.
  • Its Common Equity was $37.0 million in Q3 2025, compared to $30.4 million in Q2 2025 and $31.5 million in Q1 2025.